Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
NCT03688490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2019-07-01
Summary
Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.
Prospective work based on the distribution of a dedicated questionnaire.
Conditions
- Myeloproliferative Disorder
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Principal Investigators
-
IANOTTO Jean-Christophe, MD, PhD · Hématologie Clinique-Institut de Cancéro-Hématologie
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-17
- Primary Completion
- 2013-11-04
- Completion
- 2013-11-04
More Related Trials
-
Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
NCT01265082 ·Status: UNKNOWN
-
Carotid Plaque Burden in Patients With Philadelphia Negative Myeloproliferative Neoplasms
NCT05993052 ·Status: UNKNOWN
-
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
NCT06004817 ·Status: RECRUITING
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
NCT02993133 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
NCT03240991 ·Status: COMPLETED
-
Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease
NCT05911802 ·Status: RECRUITING
-
Mastocytosis Registry (of Zurich)
NCT06466889 ·Status: RECRUITING
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
NCT00843856 ·Status: COMPLETED ·Phase: PHASE4
-
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
NCT04845958 ·Status: COMPLETED
-
Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
NCT05353179 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Factors Regulating Mast Cell Proliferation
NCT00044122 ·Status: RECRUITING
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Screening for Prognostic Biomarkers of Severe Bell's Palsy in Adults
NCT05582915 ·Status: RECRUITING
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
NCT04018118 ·Status: RECRUITING
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
NCT02126098 ·Status: UNKNOWN
-
A Registry for Patients With Systemic Mastocytosis in China
NCT06013683 ·Status: RECRUITING
-
International Registry for Patients With Castleman Disease
NCT02817997 ·Status: RECRUITING
-
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
NCT00302549 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
NCT04161898 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3